Acquired erythropoietic protoporphyria secondary to myelodysplastic syndrome: from mythology to oncologyAcquired Erythropoietic Protoporphyria Secondary to Myelodysplastic Syndrome: From Mythology to Oncology
DOI:
https://doi.org/10.2340/actadv.v104.41146Keywords:
Porphyria, myelodysplastic syndrome, photosensitivity, erythropoietic protoporphyriaAbstract
Abstract is missing (Short communication)
Downloads
References
Snast I, Kaftory R, Sherman S, Edel Y, Hodak E, Levi A, et al. Acquired erythropoietic protoporphyria: a systematic review of the literature. Photodermatol Photoimmunol Photomed 2020; 36: 29-33.
https://doi.org/10.1111/phpp.12501 DOI: https://doi.org/10.1111/phpp.12501
Erythropoietic Protoporphyria. NCBI Bookshelf. Treasure Island, FL: StatPearls.
Maitra D, Bragazzi Cunha J, Elenbaas JS, Bonkovsky HL, Shavit JA, Omary MB. Porphyrin-induced protein oxidation and aggregation as a mechanism of porphyria-associated cell injury. Cell Mol Gastroenterol Hepatol 2019; 8: 535-548.
https://doi.org/10.1016/j.jcmgh.2019.06.006 DOI: https://doi.org/10.1016/j.jcmgh.2019.06.006
Patsatsi A, Uy CDC, Murrell DF. Multiple milia formation in blistering diseases. Int J Womens Dermatol 2020; 6: 199-202.
https://doi.org/10.1016/j.ijwd.2020.03.045 DOI: https://doi.org/10.1016/j.ijwd.2020.03.045
Yoshioka A, Fujiwara S, Kawano H, Nakano H, Taketani S, Matsui T, et al. Late-onset erythropoietic protoporphyria associated with myelodysplastic syndrome treated with azacitidine. Acta Derm Venereol 2018; 98: 275-277.
https://doi.org/10.2340/00015555-2829 DOI: https://doi.org/10.2340/00015555-2829
Suzuki H, Kikuchi K, Fukuhara N, Nakano H, Aiba S. Case of late-onset erythropoietic protoporphyria with myelodysplastic syndrome who has homozygous IVS3-48C polymorphism in the ferrochelatase gene. J Dermatol 2017; 44: 651-655.
https://doi.org/10.1111/1346-8138.13709 DOI: https://doi.org/10.1111/1346-8138.13709
Blagojevic D, Schenk T, Haas O, Zierhofer B, Konnaris C, Trautinger F. Acquired erythropoietic protoporphyria. Ann Hematol 2010; 89: 743-744.
https://doi.org/10.1007/s00277-009-0859-7 DOI: https://doi.org/10.1007/s00277-009-0859-7
Langendonk JG, Balwani M, Anderson KE, Bonkovsky HL, Anstey A V, Bissell DM, et al. Afamelanotide for erythropoietic protoporphyria. N Engl J Med 2015; 373: 48-59.
https://doi.org/10.1056/NEJMoa1411481 DOI: https://doi.org/10.1056/NEJMoa1411481
Biolcati G, Marchesini E, Sorge F, Barbieri L, Schneider-Yin X, Minder EI. Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria. Br J Dermatol 2015; 172: 1601-1612.
https://doi.org/10.1111/bjd.13598 DOI: https://doi.org/10.1111/bjd.13598
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Mirjana Urosevic-Maiwald, Jivko Kamarachev, Christoph Renner, Anna-Elisabeth Minder
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
